Bethesda criteria for microsatellite instability testing: Impact on the detection of new cases of Lynch syndrome

Familial Cancer

Volumn 11, Issue 4, 2012, Pages 571-578

  Serrano, Miguel ^a   Lage, Pedro ^a   Belga, Sara ^a   Filipe, Bruno ^a   Francisco, Inês ^a   Rodrigues, Paula ^a   Fonseca, Ricardo ^a   Chaves, Paula ^a   Claro, Isabel ^a   Albuquerque, Cristina ^a   Pereira, António Dias ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Bethesda guidelines; Lynch syndrome; Microsatellite instability; Revised Bethesda guidelines

Indexed keywords

GENOMIC DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CHILD; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENETIC ANALYSIS; GERM LINE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MISMATCH REPAIR; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GENETIC TESTING; GUIDELINES AS TOPIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; YOUNG ADULT;

EID: 84870452645     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-012-9550-6     Document Type: Article

References (43)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481-1487 (Pubitemid 28226275)
2. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788
3. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919-932 (Pubitemid 36298000)
4. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027 (Pubitemid 26113739)
5. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J et al (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621-1627
6. Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127:17-25 (Pubitemid 38962270)
7. Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491-496 (Pubitemid 40847237)
8. Peltomaki P, Vasen H (2004) Mutations associated with HNPCC predisposition -update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269-276 (Pubitemid 40164099)
9. Rustgi AK (2007) The genetics of hereditary colon cancer. Genes Dev 21:2525-2538 (Pubitemid 47607664)
10. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138:2073-2087
11. Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS et al (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645-1648 (Pubitemid 24116162)
12. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811 (Pubitemid 27097998)
13. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834 (Pubitemid 30243745)
14. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425
15. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456 (Pubitemid 29258894)
16. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM et al (1997) A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762
17. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268 (Pubitemid 38256271)
18. Jasperson KW, Tuohy TM, Neklason DW, Burt RW (2010) Hereditary and familial colon cancer. Gastroenterology 138:2044-2058
19. Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N (2001) Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 135:577-588 (Pubitemid 33010193)
20. Reyes CM, Allen BA, Terdiman JP, Wilson LS (2002) Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 95:1848-1856 (Pubitemid 35222163)
21. Pinól V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986-1994 (Pubitemid 40570892)
22. de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972-980 (Pubitemid 38198898)
23. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME et al (2006) Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354:2751-2763 (Pubitemid 43974193)
24. Balmanä J, Stockwell DH, Steyerberg EW, Stoffel EM, Deffenbaugh AM, Reid JE et al (2006) Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296:1469-1478 (Pubitemid 44465511)
25. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479-1487 (Pubitemid 44465512)
26. Tresallet C, Brouquet A, Julié C, Beauchet A, Vallot C, Ménégaux F et al (2011) Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. Int J Cancer doi. doi:10.1002/ijc.26144
27. Ferreira S, Claro I, Lage P, Filipe B, Fonseca R, Sousa R et al (2008) Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndrome. Dis Colon Rectum 51:909-915
28. Nystro?m-Lahti M, Wu Y, Moisio AL, Hofstra RM, Osinga J, Mecklin JP et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5:763-769 (Pubitemid 26171291)
29. Wu Y, Nystro?m-Lahti M, Osinga J, Looman MW, Peltomaki P, Aaltonen LA et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18:269-278 (Pubitemid 27161396)
30. Wu Y, Berends MJ, Mensink RG, Kempinga C, Sijmons RH, van Der Zee AG et al (1999) Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291-1298 (Pubitemid 30460379)
31. Holinski-Feder E, Müller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J et al (2001) DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Meth 47:21-32 (Pubitemid 32155472)
32. Rodríguez-Moranta F, Castells A, Andreu M, Pinól V, Castellví-Bel S, Alenda C et al (2006) Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol 101:1104-1111 (Pubitemid 43725327)
33. Terdiman JP, Gum JR Jr, Conrad PG, Miller GA, Weinberg V, Crawley SC et al (2001) Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 120:21-30 (Pubitemid 32061865)
34. Vasen HF (2007) Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther 26(Suppl 2):113-126 (Pubitemid 350233324)
35. Jang E, Chung D (2010) Hereditary colon cancer: Lynch syndrome. Gut Liver 4:151-160
36. Jass JR (2004) HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer 3:93-100 (Pubitemid 40645890)
37. Truta B, Chen YY, Blanco AM, Deng G, Conrad PG, Kim YH et al (2008) Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Fam Cancer 7:267-274
38. Pérez-Carbonell L, Ruiz-Ponte C, Guarinos C, Alenda C, Payá A, Brea A et al (2011) Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut. doi:gutjnl-2011-300041
39. Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E et al (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103:2825-2835
40. Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X (2011) Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol 46:1340-1348
41. Canard G, Lefevre JH, Colas C, Coulet F, Svrcek M, Lascols O et al (2011) Screening for Lynch syndrome in colorectal cancer: are we doing enough? Ann Surg Oncol. doi:10.1245/s10434-011-2014-7
42. Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (2005) Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med 129:1390-1397 (Pubitemid 41587011)
43. Balmanä J, Balaguer F, Castellví-Bel S, Steyerberg EW, Andreu M, Llor X et al (2008) Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 45:557-563